Want to join the conversation?
$ACET said that its subsidiary Rising Pharmaceuticals is launching Olopatadine Hydrochloride 0.1% Ophthalmic Solution in U.S., generic version of Alcon's Patanol, which is used for the treatment of allergic conjunctivitis. According to IMS Health data, U.S. market sales for Olopatadine were about $223MM for the twelve months ended Sept. 30, 2015.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?